EXTRAGENITAL LOCALIZATION OF SEXUALLY-TRANSMITTED DISEASES AND FLUOROQUINOLONE THERAPY OF SUCH DISEASES

Comprehensive clinical and laboratory examinations and therapy of 90 women suffering from urogenital inflammations was carried out. Gonorrhea was detected in 55 % of cases, trichomoniasis in 36.6 %, chlamydiasis in 40 %, and Ureaplasma were found in 9 % of the examinees. Gonococcal involvement of the rectum was revealed in 50 %, chlamydial involvement in 32 %, invasion with Ureaplasma and Trichomonas in 7.8 %, of cases. Detection rate of Chlamydia from the oropharynx was virtually the same as from the rectum (30 %), whereas Gonococcus and Ureaplasma were rarely detectable (5.5 and 1.1 %, respectively). Combinations of the before-said agents in the rectum were as follows: Gonococcus + Chlamydia in 15 %, Gonococcus, Chlamydia, Trichomonas in 7.3 %, Gonococcus + Ureaplasma in 7.3 %, Ureaplasma + Chlamydia in 7.8 % of cases; Gonococcus and Chlamydia were detectable from the pharynx in 3.7 % of cases. The symptoms are scanty and blurred in sexually-transmitted diseases, therefore profound clinical and laboratory examinations of the extragenital foci are advisable in patients with urogenital inflammations. Tarivid was found highly effective in the treatment of gonorrhea and ineffective for chlamydiasis; cyprobay was effective for both.